Literature DB >> 16194198

Platelet G protein-coupled receptors in hemostasis and thrombosis.

D S Woulfe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194198     DOI: 10.1111/j.1538-7836.2005.01338.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  24 in total

1.  Mapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4.

Authors:  María de la Fuente; Daniel N Noble; Sheetal Verma; Marvin T Nieman
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 2.  Platelet activation, and antiplatelet targets and agents: current and novel strategies.

Authors:  Yao-Zu Xiang; Ye Xia; Xiu-Mei Gao; Hong-Cai Shang; Li-Yuan Kang; Bo-Li Zhang
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.

Authors:  Annalisa Contursi; Angela Sacco; Rosalia Grande; Melania Dovizio; Paola Patrignani
Journal:  Cell Mol Life Sci       Date:  2017-05-09       Impact factor: 9.261

4.  Protease-activated Receptor-4 Signaling and Trafficking Is Regulated by the Clathrin Adaptor Protein Complex-2 Independent of β-Arrestins.

Authors:  Thomas H Smith; Luisa J Coronel; Julia G Li; Michael R Dores; Marvin T Nieman; JoAnn Trejo
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

5.  Anti-platelet and Anti-thrombotic Effects of a Poly-ingredient formulation: In vitro and in vivo experimental evidences.

Authors:  Mohamed Rafiq; Mohammed Azeemuddin
Journal:  Oman Med J       Date:  2012-11

6.  Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4).

Authors:  Michele M Mumaw; Maria de la Fuente; Amal Arachiche; James K Wahl; Marvin T Nieman
Journal:  Thromb Res       Date:  2015-04-09       Impact factor: 3.944

Review 7.  Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Authors:  Jennifer Yeung; Wenjie Li; Michael Holinstat
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

8.  The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.

Authors:  Chin-Chung Wu; Shih-Yun Wu; Chieh-Yu Liao; Che-Ming Teng; Yang-Chang Wu; Sheng-Chu Kuo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

9.  Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.

Authors:  Desmond J Fitzgerald; Garret A Fitzgerald
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

10.  Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis.

Authors:  M M Mumaw; M de la Fuente; D N Noble; M T Nieman
Journal:  J Thromb Haemost       Date:  2014-06-27       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.